SAU:4013

Dr. Sulaiman Al Habib Medical Services Group Company · SAU · Healthcare · SAR · FY for 2025

Figures on this page computed 2026-11-08 12:42 UTC

Last close

n/aSAR

Market data

  • 31.5xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • computed
    • Computed from the filing for 2025
  • 17.5%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 17.5%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.7%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 1.18Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 2.2%Dividend yield
    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • computed

Five bars, one line

lens 7 of 9
1.84x
1.69x
0.26x
2.44x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Sales1.84x

    Its own average over 10 years, 7.47B.

  • Profit1.69x

    Its own average over 10 years, 1.42B.

  • Free cash flow0.26x

    Its own average over 10 years, 386.9M.

  • Debt2.44x

    Its own average over 10 years, 3.82B.

  • Pricen/a

    Its own average over 0 years. Market data

Debt is furthest from its own average, at 2.44 times.

Sales is 1.84 times its own 10-year average; Profit is 1.69 times its own 10-year average; Free cash flow is 0.26 times its own 10-year average; Debt is 2.44 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 10-year average1.84
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • Profit against its own 10-year average1.69
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • Free cash flow against its own 10-year average0.26
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • Debt against its own 10-year average2.44
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    SAR

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.